CABG Medical, Inc. Announces Pricing of Public Offering

Name	Symbol	Market	Type
Carrefour Bond Matures 27mar2024	EU:CABG	Euronext	Bond

Name

Symbol

Market

Type

Carrefour Bond Matures 27mar2024

EU:CABG

Euronext

Bond

Price Change

% Change

Price

Bid Price

Offer Price

High Price

Low Price

Open Price

Traded

Last Trade

0.00

0.00%

CABG Medical, Inc. Announces Pricing of Public Offering

07/12/2004 10:30pm

PR Newswire (US)

Carrefour Bond Matures 2... (EU:CABG)
Historical Stock Chart

From May 2019 to May 2024

Click Here for more Carrefour Bond Matures 2... Charts.

CABG Medical, Inc. Announces Pricing of Public Offering MINNEAPOLIS, Dec. 7 /PRNewswire-FirstCall/ -- CABG Medical, Inc. (NASDAQ:CABG), a medical technology company seeking to improve the treatment of coronary heart disease by advancing conventional bypass surgery, today announced its public offering of 5,500,000 shares of common stock at a price of $5.50 per share. CABG Medical, Inc. has granted to the underwriters an option to purchase up to an additional 825,000 shares of common stock to cover over-allotments, if any. Feltl and Company and Ladenburg Thalmann & Co. Inc. serve as co-managers of the offering. The shares will be listed on the Nasdaq Stock Market's National Market under the symbol "CABG." The common stock offering may be made only by means of a prospectus, copies of which may be obtained by contacting Feltl and Company at 225 South Sixth Street, Suite 4200, Minneapolis, Minnesota 55402 or Ladenburg Thalmann & Co. Inc. at 590 Madison Avenue, New York, New York 10022. A registration statement relating to these securities was declared effective by the Securities and Exchange Commission on December 7, 2004. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. About the Company: CABG Medical, Inc., headquartered in Minneapolis, Minnesota, is a medical technology company seeking to improve the treatment of coronary heart disease by advancing conventional bypass surgery. We have designed our first product, the Holly Graft System, by leveraging our understanding of flow dynamics, material sciences and drug combinations to create an artificial coronary graft system. We are led by a team of experienced medical technology industry executives and recognized experts in cardiac surgery and cardiovascular research. DATASOURCE: CABG Medical, Inc. CONTACT: Manny Villafana, Chairman and Chief Executive Officer of CABG Medical, Inc., +1-763-258-8005 Web site: http://www.cabgmedical.com/

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

CABG Carrefour Bond Matures 27mar2024